SHALLCROSS STEVEN A - Insider Non-Derivative Transactions at Theriva Biologics, Inc. (TOVX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 7, 2023, SHALLCROSS STEVEN A's relationship to Theriva Biologics, Inc. (TOVX) is Director,Officer (CEO and CFO), and currently has 250,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TOVX insiders.
Data Source: SEC.
SHALLCROSS STEVEN A - Insider Non-Derivative Transactions of TOVX Common Stock
SHALLCROSS STEVEN A - Insider Non-Derivative Transactions at TOVX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 8, 2023 | P -- (Common Stock) | 14000 | 0.69 | 250000 |
| Jun 7, 2023 | P -- (Common Stock) | 26000 | 0.63 | 236000 |
| Feb 11, 2023 | P -- (Common Stock) | 25000 | 1.04 | 210000 |
| Feb 3, 2023 | P -- (Common Stock) | 25000 | 0.94 | 185000 |
| Jan 26, 2023 | P -- (Common Stock) | 25000 | 0.87 | 160000 |
| Jan 21, 2023 | P -- (Common Stock) | 25000 | 0.75 | 135000 |
| Dec 30, 2022 | P -- (Common Stock) | 100000 | 0.44 | 110000 |